← All stories
Markets 1 sources

Scholar Rock jumps 12% after FDA approves isembyld for spinal muscular atrophy

Covered by 1 source · 1 article

Covered by

All coverage

Seeking Alpha Currents 17m ago

Scholar Rock jumps 12% after FDA approves isembyld for spinal muscular atrophy

More top stories